These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30106430)

  • 1. Impact of RNA‑binding motif 3 expression on the whole transcriptome of prostate cancer cells: An RNA sequencing study.
    Dong Q; Lv C; Zhang G; Yu Z; Kong C; Fu C; Zeng Y
    Oncol Rep; 2018 Oct; 40(4):2307-2315. PubMed ID: 30106430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions.
    Grupp K; Wilking J; Prien K; Hube-Magg C; Sirma H; Simon R; Steurer S; Budäus L; Haese A; Izbicki J; Sauter G; Minner S; Schlomm T; Tsourlakis MC
    Eur J Cancer; 2014 Mar; 50(4):852-61. PubMed ID: 24380696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global transcriptome‑wide analysis of the function of GDDR in acute gastric lesions.
    Zhang Z; Zhu J; Dong Y; Xu H; Jiang T; Li W; Xu D; Shi L; Yu J; Zhang J; Du J
    Mol Med Rep; 2017 Dec; 16(6):8673-8684. PubMed ID: 28990076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress-response protein RBM3 attenuates the stem-like properties of prostate cancer cells by interfering with CD44 variant splicing.
    Zeng Y; Wodzenski D; Gao D; Shiraishi T; Terada N; Li Y; Vander Griend DJ; Luo J; Kong C; Getzenberg RH; Kulkarni P
    Cancer Res; 2013 Jul; 73(13):4123-33. PubMed ID: 23667174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of prognosis biomarkers of prostatic cancer in a cohort of 498 patients from TCGA.
    Chen Z; Hu H
    Curr Probl Cancer; 2019 Dec; 43(6):100503. PubMed ID: 31563279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes.
    Thiemeyer H; Taher L; Schille JT; Packeiser EM; Harder LK; Hewicker-Trautwein M; Brenig B; Schütz E; Beck J; Nolte I; Murua Escobar H
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both genes and lncRNAs can be used as biomarkers of prostate cancer by using high throughput sequencing data.
    Cheng WS; Tao H; Hu EP; Liu S; Cai HR; Tao XL; Zhang L; Mao JJ; Yan DL
    Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3504-10. PubMed ID: 25491628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance.
    Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Kwon K; Jang CS; Noh YH; Kim SY
    Cancer Genomics Proteomics; 2015; 12(3):153-66. PubMed ID: 25977174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of key genes associated with prostate cancer using RNA-seq data.
    Wu J; Feng F; Yang D; Yu S; Liu J; Gao Z
    Int J Biol Markers; 2014 Mar; 29(1):e86-92. PubMed ID: 24366848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variant analysis of prostate cancer in Japanese patients and a new attempt to predict related biological pathways.
    Kasajima R; Yamaguchi R; Shimizu E; Tamada Y; Niida A; Tremmel G; Kishida T; Aoki I; Imoto S; Miyano S; Uemura H; Miyagi Y
    Oncol Rep; 2020 Mar; 43(3):943-952. PubMed ID: 32020225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis of fibroblasts exposed to TGF‑β at the early proliferation phase of wound repair.
    Mi B; Liu G; Zhou W; Lv H; Zha K; Liu Y; Wu Q; Liu J
    Mol Med Rep; 2017 Dec; 16(6):8146-8154. PubMed ID: 28983581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome sequencing identifies key pathways and genes involved in gastric adenocarcinoma.
    Zhang W; Liu S; Zhan H; Yan Z; Zhang G
    Mol Med Rep; 2018 Oct; 18(4):3673-3682. PubMed ID: 30106143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNAs and genes contributing to the generation of cancer stem cells in hepatocellular carcinoma identified by RNA sequencing analysis.
    Cao L; Zhang Q; Cheng S; Chen Z; Hua Z; Yang J; Liu D; Cui N
    Oncol Rep; 2016 Nov; 36(5):2619-2624. PubMed ID: 27667473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the therapeutic potential and mechanism of curcumin in breast cancer based on RNA sequencing and bioinformatics analysis.
    Wang R; Li J; Zhao Y; Li Y; Yin L
    Breast Cancer; 2018 Mar; 25(2):206-212. PubMed ID: 29139094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
    Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic analysis of mRNA expression profiles in NSCLC cell lines to screen metastasis-related genes.
    Liu Y; Liu L; Yu T; Lin HC; Chu D; Deng W; Yan MX; Li J; Yao M
    Mol Med Rep; 2016 Dec; 14(6):5093-5103. PubMed ID: 27840927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia.
    Hirai K; Nomura T; Yamasaki M; Inoue T; Narimatsu T; Chisato Nakada PD; Yoshiyuki Tsukamoto PD; Matsuura K; Sato F; Moriyama M; Mimata H
    Urol Oncol; 2014 Feb; 32(2):101-9. PubMed ID: 23403204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.